bih.button.backtotop.text

Bumrungrad Health Blog

Selected Filter (s): All

Type : All

Clear All

10 Effective Habits to Successfully Lose Weight

Being overweight or obese is not just about appearance. They are health conditions that directly affect a person’s overall well-being. Excess weight can impact the heart, blood vessels, liver, kidneys, joints, and even mental health.

Read more

Do Weight Control Injections (Weight-Loss Pens) Really Work?

Weight loss injections (weight-loss pens) help treat obesity by reducing appetite and controlling blood sugar, and should be used under medical supervision with lifestyle changes for lasting results.

Read more

Know Your BMI: What Your Means

Know Your BMI: What Your Means

Read more

A Non-Surgical Solution for Weight Loss

When lifestyle changes and medication are not enough, Endoscopic Sleeve Gastroplasty (ESG) may be an effective option for weight management.

Read more

Injectable Weight Loss Medications: A New Option for Obesity Management

New-generation injectable medications, particularly Semaglutide and Tirzepatide, have demonstrated significant weight reduction, making them promising options for obesity management under medical supervision.

Read more

ESG vs. Bariatric Surgery vs. GLP-1 Therapy: Where Do We Stand in 2025?

Obesity affects over a third of adults, fueling diabetes and heart disease. In 2025, advanced medical options like Endoscopic Sleeve Gastroplasty (ESG), bariatric surgery, and GLP-1 medications offer powerful support beyond lifestyle changes.

Read more

Endoscopic Sleeve Gastroplasty (ESG) and GLP-1 Therapy in 2025: A Comprehensive Guide to the Future of Bariatric Endoscopy

Endoscopic Sleeve Gastroplasty (ESG) and GLP-1 meds like semaglutide offer a powerful, minimally invasive way to combat obesity and its complications. Bumrungrad reports up to 44% weight loss success.

Read more

Revolutionary Weight Loss Approach: ESG and GLP-1 Drugs Combined

A transformative study has shown that combining Endoscopic Sleeve Gastroplasty (ESG) with GLP-1 receptor agonist drugs, such semaglutide, delivers superior weight loss results compared to ESG alone. It is changing the landscape of obesity treatment.

Read more

Cost-Effective Weight Loss: Endoscopic Sleeve Gastroplasty Outperforms GLP-1 Drugs

Obesity is a significant health concern, affecting millions and placing a heavy burden on healthcare systems. If you’re exploring weight-loss options, two effective approaches are Endoscopic Sleeve Gastroplasty (ESG) and GLP-1 drugs like semaglutide.

Read more